These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 20501720)
1. Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Tsuboyama T; Onishi H; Kim T; Akita H; Hori M; Tatsumi M; Nakamoto A; Nagano H; Matsuura N; Wakasa K; Tomoda K Radiology; 2010 Jun; 255(3):824-33. PubMed ID: 20501720 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. Kitao A; Zen Y; Matsui O; Gabata T; Kobayashi S; Koda W; Kozaka K; Yoneda N; Yamashita T; Kaneko S; Nakanuma Y Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969 [TBL] [Abstract][Full Text] [Related]
3. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease. Lee MH; Kim SH; Park MJ; Park CK; Rhim H AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584 [TBL] [Abstract][Full Text] [Related]
6. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092 [TBL] [Abstract][Full Text] [Related]
7. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging. Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677 [TBL] [Abstract][Full Text] [Related]
8. OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. Ueno A; Masugi Y; Yamazaki K; Komuta M; Effendi K; Tanami Y; Tsujikawa H; Tanimoto A; Okuda S; Itano O; Kitagawa Y; Kuribayashi S; Sakamoto M J Hepatol; 2014 Nov; 61(5):1080-7. PubMed ID: 24946283 [TBL] [Abstract][Full Text] [Related]
9. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Kang Y; Lee JM; Kim SH; Han JK; Choi BI Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225 [TBL] [Abstract][Full Text] [Related]
10. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Ahn SS; Kim MJ; Lim JS; Hong HS; Chung YE; Choi JY Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759 [TBL] [Abstract][Full Text] [Related]
12. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns. Park MJ; Kim YK; Lee MW; Lee WJ; Kim YS; Kim SH; Choi D; Rhim H Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769 [TBL] [Abstract][Full Text] [Related]
13. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC. Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358 [TBL] [Abstract][Full Text] [Related]
14. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. Kim JE; Kim SH; Lee SJ; Rhim H AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265 [TBL] [Abstract][Full Text] [Related]
16. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging. Tsuda N; Matsui O Radiology; 2010 Sep; 256(3):767-73. PubMed ID: 20663976 [TBL] [Abstract][Full Text] [Related]
17. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. Suh YJ; Kim MJ; Choi JY; Park YN; Park MS; Kim KW AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994 [TBL] [Abstract][Full Text] [Related]
18. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. Ba-Ssalamah A; Antunes C; Feier D; Bastati N; Hodge JC; Stift J; Cipriano MA; Wrba F; Trauner M; Herold CJ; Caseiro-Alves F Radiology; 2015 Oct; 277(1):104-13. PubMed ID: 25985059 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics. Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Sanada J; Koda W; Minami T; Inoue D; Yoshida K; Yamashita T; Yamashita T; Kaneko S; Takamura H; Ohta T; Ikeda H; Nakanuma Y; Kita R; Gabata T Radiology; 2015 Jun; 275(3):708-17. PubMed ID: 25668519 [TBL] [Abstract][Full Text] [Related]
20. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. Jang KM; Kim SH; Kim YK; Choi D Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]